StockData
Clene Inc. logo

Clene Inc. (CLNN) stock

CLNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 1/30
$3.42+0.20 (+6.21%)

Close on Nov 18, 2026Market cap $43.94MP/E –Yield –

Clene shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Clene's shares outstanding was 12M at Jun 30, 2026. For fiscal 2025 it was 10M, up 41.8% from the year before. The highest annual figure on record is 10M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202510M+41.8%
FY2024Dec 31, 20247M+32.5%
FY2023Dec 31, 20235M+60.9%
FY2022Dec 31, 20223M+5.9%
FY2021Dec 31, 20213M+251.7%
FY2020Dec 31, 20201M+0.8%
FY2019Dec 31, 20191M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202612M+30.0%
Q1 FY2026Mar 31, 202612M+32.0%
Q4 FY2025Dec 31, 202511M+28.2%
Q3 FY2025Sep 30, 202510M+56.8%
Q2 FY2025Jun 30, 202510M+48.3%
Q1 FY2025Mar 31, 20259M+37.4%
Q4 FY2024Dec 31, 20248M+30.8%
Q3 FY2024Sep 30, 20247M+2.1%
Q2 FY2024Jun 30, 20246M+49.3%
Q1 FY2024Mar 31, 20246M+68.9%
Q4 FY2023Dec 31, 20236M+103.2%
Q3 FY2023Sep 30, 20236M+104.3%
Q2 FY2023Jun 30, 20234M+38.1%
Q1 FY2023Mar 31, 20234M+8.6%
Q2 FY2022Jun 30, 20223M+3.5%
Q1 FY2022Mar 31, 20223M+3.6%
Q4 FY2021Dec 31, 20213M+247.3%
Q3 FY2021Sep 30, 20214M+303.5%
Q2 FY2021Jun 30, 20213M+252.4%
Q1 FY2021Mar 31, 20213M+249.5%
Q4 FY2020Dec 31, 20201M–
Q3 FY2020Sep 30, 20201M–
Q2 FY2020Jun 30, 20201M–
Q1 FY2020Mar 31, 20201M–

More Clene figures

See a number that looks wrong?